Hugh Lin

Hugh Lin

Company: Genentech

Job title: Global Development Leader – Faricimab

Seminars:

Chair Led Q&A: Latest Case Studies Tackling the VEGF Pathway 12:55 pm

Read more

day: Day Two

Faricimab: Developing a Ophthalmologic Bispecific Therapeutic for AMD & DME 12:05 pm

• Reviewing Ang-2 biology/Bispecific technology attributes • Existing phase 3 trial designs • Reviewing available clinical dataRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.